Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer ...

UTSA: ~20% of AI-suggested packages don't exist. Slopsquatting could let attackers slip malicious libs into projects.

HCPs and key opinion leaders (KOLs) have always been central to the success of new therapies, shaping how innovations reach ...

A recent survey from State Street Investment Management* finds that 77 per cent of asset owners in EMEA that responded are integrating nature and biodiversity into their investment strategies.  One ...

During the holiday season I’ve had the heartwarming experience of seeing many young children following along with their ...

A question from his granddaughter sparked Ed Scheinerman's new book, 'A Guide to Infinity', where he shows that infinity ...

Claude Sonnet 4.6 is now free for everyone — and it's more powerful than ever. Here are the five best things to try first on ...

Potential player two is the pre-digital native. If you’re in this camp then you grew up before video games became established ...

The FORGE method is a 5-step Claude framework that takes any rough idea from messy to complete — and keeps you in control of ...

Q4 2025 earnings call: ivonescimab Phase III updates, FDA PDUFA timeline, interim PFS in Q2 2026, cash position—read now.

This study will update and extend How People Learn: Brain, Mind, Experience, and School (2000) by examining the research that has emerged across various disciplines that focus on the study of learning ...

Q4 2025 earnings call recap: lonvo-z Phase III timeline, MAGNITUDE-2 FDA hold lifted, cash runway and launch plans—read now.